Pazopanib in relapsed osteosarcoma patients: report on 15 cases

Acta Oncol. 2019 Jan;58(1):124-128. doi: 10.1080/0284186X.2018.1503714. Epub 2018 Sep 12.

Authors

Affiliations

¹ a Department of Chemotherapy , IRCCS Istituto Ortopedico Rizzoli , Bologna , Italy.
² b Department of Radiology , IRCCS Istituto Ortopedico Rizzoli , Bologna , Italy.
³ c Orthopedic Surgery, Orthopedic Oncologic Surgery , IRCCS Istituto Ortopedico Rizzoli , Bologna , Italy.
⁴ d Department of Oncology , Oslo University Hospital, The Norwegian Radium Hospital , Oslo , Norway.

PMID: 30207179
DOI: 10.1080/0284186X.2018.1503714

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Adult
Aged
Angiogenesis Inhibitors / therapeutic use*
Bone Neoplasms / drug therapy*
Bone Neoplasms / mortality
Child
Female
Humans
Indazoles
Male
Middle Aged
Neoplasm Recurrence, Local / drug therapy*
Neoplasm Recurrence, Local / mortality
Osteosarcoma / drug therapy*
Osteosarcoma / mortality
Progression-Free Survival
Pyrimidines / therapeutic use*
Salvage Therapy / methods
Sulfonamides / therapeutic use*
Young Adult

Substances

Angiogenesis Inhibitors
Indazoles
Pyrimidines
Sulfonamides
pazopanib